This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Caterina Mazzoni: Pioneer in Dopamine D3 Receptor Modulation
Introduction:
Caterina Mazzoni, a talented inventor based in Verona, Italy, has made significant strides in the field of pharmaceuticals with her innovative work on dopamine D3 receptor modulators.
Latest Patents:
Caterina Mazzoni holds one patent for Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors, showcasing her profound expertise in developing novel compounds for therapeutic purposes.
Career Highlights:
Mazzoni's career highlights include her pivotal role at Glaxo Group Limited, where she has contributed to groundbreaking research and development in the pharmaceutical industry. Her dedication to advancing medicine through her inventions has garnered widespread recognition.
Collaborations:
Throughout her career, Caterina Mazzoni has collaborated closely with esteemed colleagues such as Dieter Hamprecht and Fabrizio Micheli. Their combined efforts have led to the successful creation of innovative pharmaceutical solutions that have the potential to revolutionize patient care.
Conclusion:
In conclusion, Caterina Mazzoni's pioneering work in the development of dopamine D3 receptor modulators underscores her as a trailblazer in the pharmaceutical industry. Her relentless pursuit of innovation and collaboration with top experts reaffirms her position as a leading figure in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile